NCT03121599View on ClinicalTrials.gov

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 11, 2017

Primary Completion Date

October 15, 2018

Study Completion Date

October 16, 2018

Conditions
Essential ThrombocythemiaPrimary Myelofibrosis, Fibrotic StagePrimary Myelofibrosis, Prefibrotic StagePolycythemia Vera
Interventions
DEVICE

Diagnostic (18F-FLT PET/CT)

The tracer compound \[F-18\] FLT will be injected into the patient's veins in a small volume of normal saline solution. The PET scan data collection is started immediately and is continued for 2 hours.

Trial Locations (1)

Unknown

National Center for Cancer Care & Research (NCCCR), Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY